Literature DB >> 8038683

Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome.

H Helbig1, U Schlötzer-Schrehardt, W Noske, U Kellner, M H Foerster, G O Naumann.   

Abstract

Iris vasculopathy is a well-recognized clinical feature in pseudoexfoliation syndrome (PES). In the present study we examined the morphology of the iris vasculature in PES using electron microscopy and we tested whether these iris vascular changes were correlated with an impaired oxygen supply to the anterior chamber. In the affected vessels we found a gradual degeneration of vascular cells, progressing from adventitial to endothelial cells, associated with the production of excess extracellular material, including pseudoexfoliative fibers. Oxygen partial pressure (pO2) was measured in the anterior chamber during cataract surgery using a polarographic oxygen electrode in eyes with and without PES. The pO2 value measured in the anterior chamber of 10 eyes without PES was 45 +/- 11 mmHg (mean +/- SD) in the chamber angle, 33 +/- 12 mmHg in front of the pupillary margin, and 13 +/- 8 mmHg in the center of the pupil. This spatial distribution of pO2 indicates that aqueous humor oxygenation occurs along the anterior iris surface. The mean pO2 values obtained in 8 patients with PES were 19 +/- 6 mmHg in the chamber angle, 16 +/- 4 mmHg in front of the pupillary margin, and 8 +/- 3 mmHg in the center of the pupil. We conclude that anterior-chamber hypoxia due to iris vasculopathy may represent a complication of PES that could play a role in the pathogenesis of PES-associated alterations in the anterior segment of the eye.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8038683

Source DB:  PubMed          Journal:  Ger J Ophthalmol        ISSN: 0941-2921


  32 in total

1.  Serum and aqueous xanthine oxidase levels, and mRNA expression in anterior lens epithelial cells in pseudoexfoliation.

Authors:  Huseyin Simavli; Mehmet Tosun; Yasin Y Bucak; Mesut Erdurmus; Zeynep Ocak; Halil I Onder; Muradiye Acar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-10       Impact factor: 3.117

2.  Cerebrovascular blood flow velocities in pseudoexfoliation.

Authors:  Nurşen Yüksel; Yonca Anik; Aysun Kiliç; Vlevent Karabaş; Ali Demirci; Yusuf Cağlar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-13       Impact factor: 3.117

3.  Pseudoexfoliation syndrome: analysis of systemic comorbidities of 325 PEX-positive patients compared with 911 PEX-negative patients.

Authors:  Elizabeth Scharfenberg; Franziska G Rauscher; Petra Meier; Dirk Hasenclever
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-16       Impact factor: 3.117

4.  Pseudoexfoliation syndrome and secondary cataract.

Authors:  M Küchle; A Amberg; P Martus; N X Nguyen; G O Naumann
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

Review 5.  Ocular oxygen measurement.

Authors:  I M Hogeboom van Buggenum; G L van der Heijde; G J Tangelder; J W Reichert-Thoen
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

6.  Blood-aqueous barrier in pseudoexfoliation syndrome: evaluation by immunohistochemical staining of endogenous albumin.

Authors:  M Küchle; S A Vinores; J Mahlow; W R Green
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

7.  Analyzing cytokines as biomarkers to evaluate severity of glaucoma.

Authors:  Yao Tong; Ya-Li Zhou; Yan Zheng; Manas Biswal; Pei-Quan Zhao; Zhao-Yang Wang
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

8.  YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome.

Authors:  Tansu Gonen; Savas Guzel; Kadircan H Keskinbora
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

9.  Macula Vessel Density and Foveal Avascular Zone Parameters in Exfoliation Glaucoma Compared to Primary Open-Angle Glaucoma.

Authors:  Shawn Philip; Ahmad Najafi; Apichat Tantraworasin; Toco Y P Chui; Richard B Rosen; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-03-01       Impact factor: 4.799

10.  Genetics, Diagnosis, and Monitoring of Pseudoexfoliation Glaucoma.

Authors:  Niraj Nathan; Rachel W Kuchtey
Journal:  Curr Ophthalmol Rep       Date:  2016-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.